Please enable JavaScript to continue using this application.

Compare $KURA vs $SVRA | Chartloom

Compare

$KURA vs $SVRA

Kura Oncology Inc · Savara Inc

KURA

Kura Oncology Inc

SVRA

Savara Inc

Compare $KURA vs $SVRA

Comparing Kura Oncology Inc and Savara Inc

KURAKura Oncology Inc

SVRASavara Inc

KURAKura Oncology Inc

Market cap

$941M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.49x

Rev growth (TTM)

-7.3%

YTD performance

2.6%

52W performance

5.2%

FCF yield

-12.5%

SVRASavara Inc

Market cap

$1.01B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

22.71x

Rev growth (TTM)

—

YTD performance

-12.8%

52W performance

41.8%

FCF yield

-11.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KURA

SVRA

Detailed metrics comparison

KURA

Kura Oncology Inc

SVRA

Savara Inc

Market Cap

KURA$941M

SVRA$1.01B

Enterprise Value

KURA$881M

SVRA$997M

Price

KURA$10.60

SVRA$4.92

P/E Ratio

KURAN/A

SVRAN/A

P/S Ratio

KURA12.18x

SVRA3,801.01x

EV/Sales

KURA11.40x

SVRA3,756.05x

EV/EBITDA

KURA0.00x

SVRA0.00x

P/B Ratio

KURA19.56x

SVRA6.88x

P/FCF Ratio

KURAN/A

SVRAN/A

EV/FCF

KURA-7.50x

SVRA-9.01x

PEG Ratio

KURAN/A

SVRAN/A

Forward P/E (NTM)

KURAN/A

SVRAN/A

Forward P/S (NTM)

KURA6.49x

SVRA22.71x

Revenue (TTM)

KURA$77M

SVRA$0

Revenue Growth (YoY)

KURA-7.3%

SVRAN/A

Forward Rev Growth

KURA106.3%

SVRA3388.8%

Gross Margin (TTM)

KURA72.4%

SVRA0.0%

Operating Margin (TTM)

KURA0.0%

SVRA0.0%

EBITDA Margin (TTM)

KURA-410.2%

SVRA0.0%

Net Margin (TTM)

KURA-384.3%

SVRA0.0%

FCF Margin (TTM)

KURA-152.1%

SVRAN/A

Net Income (TTM)

KURA$-297M

SVRA$-139M

FCF (TTM)

KURA$-117M

SVRA$-111M

EPS (TTM)

KURA-$3.34

SVRA-$0.55

ROE (TTM)

KURA-20718.0%

SVRA-9028.0%

ROA (TTM)

KURA-4517.0%

SVRA-6895.0%

ROIC (TTM)

KURA-19400.0%

SVRA-7560.0%

Cash

KURA$70M

SVRA$42M

Debt

KURA$10M

SVRA$30M

Net Cash/Debt

KURA$60M

SVRA$12M

Current Ratio (TTM)

KURA4.73x

SVRA10.13x

Quick Ratio (TTM)

KURA4.47x

SVRA10.00x

Debt/Equity (TTM)

KURA0.20x

SVRA0.21x

Debt/Assets (TTM)

KURA0.0%

SVRA0.0%

Interest Coverage (TTM)

KURAN/A

SVRAN/A

Net Debt/EBITDA (TTM)

KURA0.00x

SVRA0.00x

Beta

KURA0.53

SVRA0.28

52W Performance

KURA5.2%

SVRA41.8%

YTD Performance

KURA2.6%

SVRA-12.8%

% from 52W High

KURA-23.7%

SVRA-29.8%

% from 52W Low

KURA44.1%

SVRA46.9%

Asset Turnover (TTM)

KURA0.12x

SVRA0.00x

FCF Yield (TTM)

KURA-12.5%

SVRA-11.0%

Earnings Yield (TTM)

KURA-31.5%

SVRA-13.8%

Dividend Yield (TTM)

KURAN/A

SVRAN/A

Rule of 40

KURA-159.3

SVRA0.0

EV/GP/RG

KURA0.09

SVRAN/A

Ticker research

View KURA research View SVRA research

Metric	KURA Kura Oncology Inc	SVRA Savara Inc
Market & Valuation
Market Cap	$941M	$1.01B
Enterprise Value	$881M	$997M
Price	$10.60	$4.92
P/E Ratio	N/A	N/A
P/S Ratio	12.18x	3,801.01x
EV/Sales	11.40x	3,756.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.56x	6.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-9.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.49x	22.71x
Revenue & Growth
Revenue (TTM)	$77M	$0
Revenue Growth (YoY)	-7.3%	N/A
Forward Rev Growth	106.3%	3388.8%
Profitability
Gross Margin (TTM)	72.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.2%	0.0%
Net Margin (TTM)	-384.3%	0.0%
FCF Margin (TTM)	-152.1%	N/A
Net Income (TTM)	$-297M	$-139M
FCF (TTM)	$-117M	$-111M
EPS (TTM)	-$3.34	-$0.55
ROE (TTM)	-20718.0%	-9028.0%
ROA (TTM)	-4517.0%	-6895.0%
ROIC (TTM)	-19400.0%	-7560.0%
Financial Health
Cash	$70M	$42M
Debt	$10M	$30M
Net Cash/Debt	$60M	$12M
Current Ratio (TTM)	4.73x	10.13x
Quick Ratio (TTM)	4.47x	10.00x
Debt/Equity (TTM)	0.20x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.53	0.28
52W Performance	5.2%	41.8%
YTD Performance	2.6%	-12.8%
% from 52W High	-23.7%	-29.8%
% from 52W Low	44.1%	46.9%
Efficiency & Yields
Asset Turnover (TTM)	0.12x	0.00x
FCF Yield (TTM)	-12.5%	-11.0%
Earnings Yield (TTM)	-31.5%	-13.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-159.3	0.0
EV/GP/RG	0.09	N/A
Ticker research	View KURA research	View SVRA research

Valuation

P/S Ratio

KURA

12.18x

SVRA

3,801.01x

EV/FCF

SVRA

-9.01x

KURA

-7.50x

Growth & revenue

Revenue Growth TTM

KURA

-7.3%

Forward Revenue Growth

SVRA

3388.8%

KURA

106.3%

Profitability & performance

Gross Margin

KURA

72.4%

SVRA

0.0%

ROE

SVRA

-9028.0%

KURA

-20718.0%

FCF Yield %

SVRA

-11.0%

KURA

-12.5%

52-Week Performance

SVRA

41.8%

KURA

5.2%

Detailed metrics comparison

KURA

Kura Oncology Inc

SVRA

Savara Inc

Market Cap

KURA$941M

SVRA$1.01B

Enterprise Value

KURA$881M

SVRA$997M

Price

KURA$10.60

SVRA$4.92

P/E Ratio

KURAN/A

SVRAN/A

P/S Ratio

KURA12.18x

SVRA3,801.01x

EV/Sales

KURA11.40x

SVRA3,756.05x

EV/EBITDA

KURA0.00x

SVRA0.00x

P/B Ratio

KURA19.56x

SVRA6.88x

P/FCF Ratio

KURAN/A

SVRAN/A

EV/FCF

KURA-7.50x

SVRA-9.01x

PEG Ratio

KURAN/A

SVRAN/A

Forward P/E (NTM)

KURAN/A

SVRAN/A

Forward P/S (NTM)

KURA6.49x

SVRA22.71x

Revenue (TTM)

KURA$77M

SVRA$0

Revenue Growth (YoY)

KURA-7.3%

SVRAN/A

Forward Rev Growth

KURA106.3%

SVRA3388.8%

Gross Margin (TTM)

KURA72.4%

SVRA0.0%

Operating Margin (TTM)

KURA0.0%

SVRA0.0%

EBITDA Margin (TTM)

KURA-410.2%

SVRA0.0%

Net Margin (TTM)

KURA-384.3%

SVRA0.0%

FCF Margin (TTM)

KURA-152.1%

SVRAN/A

Net Income (TTM)

KURA$-297M

SVRA$-139M

FCF (TTM)

KURA$-117M

SVRA$-111M

EPS (TTM)

KURA-$3.34

SVRA-$0.55

ROE (TTM)

KURA-20718.0%

SVRA-9028.0%

ROA (TTM)

KURA-4517.0%

SVRA-6895.0%

ROIC (TTM)

KURA-19400.0%

SVRA-7560.0%

Cash

KURA$70M

SVRA$42M

Debt

KURA$10M

SVRA$30M

Net Cash/Debt

KURA$60M

SVRA$12M

Current Ratio (TTM)

KURA4.73x

SVRA10.13x

Quick Ratio (TTM)

KURA4.47x

SVRA10.00x

Debt/Equity (TTM)

KURA0.20x

SVRA0.21x

Debt/Assets (TTM)

KURA0.0%

SVRA0.0%

Interest Coverage (TTM)

KURAN/A

SVRAN/A

Net Debt/EBITDA (TTM)

KURA0.00x

SVRA0.00x

Beta

KURA0.53

SVRA0.28

52W Performance

KURA5.2%

SVRA41.8%

YTD Performance

KURA2.6%

SVRA-12.8%

% from 52W High

KURA-23.7%

SVRA-29.8%

% from 52W Low

KURA44.1%

SVRA46.9%

Asset Turnover (TTM)

KURA0.12x

SVRA0.00x

FCF Yield (TTM)

KURA-12.5%

SVRA-11.0%

Earnings Yield (TTM)

KURA-31.5%

SVRA-13.8%

Dividend Yield (TTM)

KURAN/A

SVRAN/A

Rule of 40

KURA-159.3

SVRA0.0

EV/GP/RG

KURA0.09

SVRAN/A

Ticker research

View KURA research View SVRA research

Metric	KURA Kura Oncology Inc	SVRA Savara Inc
Market & Valuation
Market Cap	$941M	$1.01B
Enterprise Value	$881M	$997M
Price	$10.60	$4.92
P/E Ratio	N/A	N/A
P/S Ratio	12.18x	3,801.01x
EV/Sales	11.40x	3,756.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.56x	6.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-9.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.49x	22.71x
Revenue & Growth
Revenue (TTM)	$77M	$0
Revenue Growth (YoY)	-7.3%	N/A
Forward Rev Growth	106.3%	3388.8%
Profitability
Gross Margin (TTM)	72.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.2%	0.0%
Net Margin (TTM)	-384.3%	0.0%
FCF Margin (TTM)	-152.1%	N/A
Net Income (TTM)	$-297M	$-139M
FCF (TTM)	$-117M	$-111M
EPS (TTM)	-$3.34	-$0.55
ROE (TTM)	-20718.0%	-9028.0%
ROA (TTM)	-4517.0%	-6895.0%
ROIC (TTM)	-19400.0%	-7560.0%
Financial Health
Cash	$70M	$42M
Debt	$10M	$30M
Net Cash/Debt	$60M	$12M
Current Ratio (TTM)	4.73x	10.13x
Quick Ratio (TTM)	4.47x	10.00x
Debt/Equity (TTM)	0.20x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.53	0.28
52W Performance	5.2%	41.8%
YTD Performance	2.6%	-12.8%
% from 52W High	-23.7%	-29.8%
% from 52W Low	44.1%	46.9%
Efficiency & Yields
Asset Turnover (TTM)	0.12x	0.00x
FCF Yield (TTM)	-12.5%	-11.0%
Earnings Yield (TTM)	-31.5%	-13.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-159.3	0.0
EV/GP/RG	0.09	N/A
Ticker research	View KURA research	View SVRA research